RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
03 10 2019
Historique:
received: 15 11 2018
revised: 23 05 2019
accepted: 26 06 2019
pubmed: 12 8 2019
medline: 20 2 2020
entrez: 12 8 2019
Statut: ppublish

Résumé

Alternative lengthening of telomeres (ALT) is a homology-directed repair (HDR) mechanism of telomere elongation that controls proliferation in aggressive cancers. We show that the disruption of RAD51-associated protein 1 (RAD51AP1) in ALT+ cancer cells leads to generational telomere shortening. This is due to RAD51AP1's involvement in RAD51-dependent homologous recombination (HR) and RAD52-POLD3-dependent break induced DNA synthesis. RAD51AP1 KO ALT+ cells exhibit telomere dysfunction and cytosolic telomeric DNA fragments that are sensed by cGAS. Intriguingly, they activate ULK1-ATG7-dependent autophagy as a survival mechanism to mitigate DNA damage and apoptosis. Importantly, RAD51AP1 protein levels are elevated in ALT+ cells due to MMS21 associated SUMOylation. Mutation of a single SUMO-targeted lysine residue perturbs telomere dynamics. These findings indicate that RAD51AP1 is an essential mediator of the ALT mechanism and is co-opted by post-translational mechanisms to maintain telomere length and ensure proliferation of ALT+ cancer cells.

Identifiants

pubmed: 31400850
pii: S1097-2765(19)30500-3
doi: 10.1016/j.molcel.2019.06.043
pmc: PMC6778027
mid: NIHMS1533834
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
Intracellular Signaling Peptides and Proteins 0
RAD51AP1 protein, human 0
RAD52 protein, human 0
RNA-Binding Proteins 0
Rad52 DNA Repair and Recombination Protein 0
Autophagy-Related Protein-1 Homolog EC 2.7.11.1
ULK1 protein, human EC 2.7.11.1
Nucleotidyltransferases EC 2.7.7.-
POLD3 protein, human EC 2.7.7.-
cGAS protein, human EC 2.7.7.-
DNA Polymerase III EC 2.7.7.7
Ligases EC 6.-
ATG7 protein, human EC 6.2.1.45
Autophagy-Related Protein 7 EC 6.2.1.45
NSMCE2 protein, human EC 6.3.2.-
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-26.e7

Subventions

Organisme : NIH HHS
ID : S10 OD019973
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES024872
Pays : United States
Organisme : NIH HHS
ID : S10 OD010625
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207209
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Genes Dev. 2019 Feb 1;33(3-4):221-235
pubmed: 30692206
Science. 1994 Dec 23;266(5193):2011-5
pubmed: 7605428
Cell Rep. 2019 Jan 22;26(4):955-968.e3
pubmed: 30673617
Mol Cell. 2007 Nov 9;28(3):482-90
pubmed: 17996711
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
EMBO Rep. 2009 Feb;10(2):173-9
pubmed: 19148225
Nat Commun. 2017 Jan 18;8:14109
pubmed: 28098164
Mol Cell. 2016 Dec 15;64(6):1117-1126
pubmed: 27984745
Nat Struct Mol Biol. 2007 Jul;14(7):581-90
pubmed: 17589526
Nat Rev Mol Cell Biol. 2007 Dec;8(12):947-56
pubmed: 18000527
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71
pubmed: 21102611
J Biol Chem. 1997 Nov 7;272(45):28557-62
pubmed: 9353319
Mol Cell. 2016 Dec 15;64(6):1127-1134
pubmed: 27984746
Cell Cycle. 2016 Oct;15(19):2636-2646
pubmed: 27463890
Nat Struct Mol Biol. 2017 Mar;24(3):325-336
pubmed: 28112733
Nat Genet. 2000 Dec;26(4):447-50
pubmed: 11101843
Trends Cell Biol. 2017 May;27(5):340-351
pubmed: 28011061
Nature. 2015 Nov 5;527(7576):105-9
pubmed: 26524528
Nat Struct Mol Biol. 2014 Feb;21(2):167-74
pubmed: 24413054
Cell. 2016 Jul 28;166(3):651-663
pubmed: 27374333
Science. 2011 Jan 28;331(6016):456-61
pubmed: 21205641
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Genes Dev. 2011 Sep 1;25(17):1847-58
pubmed: 21896657
Cell Rep. 2016 Jun 7;15(10):2118-2126
pubmed: 27239033
Cell Cycle. 2012 Jan 1;11(1):170-6
pubmed: 22185757
Cell. 2009 Jul 10;138(1):90-103
pubmed: 19596237
Mol Cell. 2007 Nov 9;28(3):468-81
pubmed: 17996710
Cell Rep. 2012 Dec 27;2(6):1521-9
pubmed: 23260663
Nature. 2019 Mar;567(7747):262-266
pubmed: 30842662
Nat Struct Mol Biol. 2009 Dec;16(12):1244-51
pubmed: 19935685
Mol Cell. 2015 Jul 16;59(2):285-97
pubmed: 26118643
Cell Rep. 2016 Nov 8;17(7):1858-1871
pubmed: 27829156
Mol Cell Biol. 2005 Aug;25(16):7021-32
pubmed: 16055714
Oncotarget. 2018 Mar 23;9(22):15836-15846
pubmed: 29662610
Nature. 2016 Nov 3;539(7627):54-58
pubmed: 27760120
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Cell. 2013 Oct 24;155(3):688-98
pubmed: 24119841
Cell Host Microbe. 2014 Feb 12;15(2):228-38
pubmed: 24528868
Mol Cell. 2013 Mar 7;49(5):795-807
pubmed: 23416108
Science. 2011 Jul 22;333(6041):425
pubmed: 21719641
Nat Med. 1997 Nov;3(11):1271-4
pubmed: 9359704
EMBO J. 2017 Oct 2;36(19):2907-2919
pubmed: 28877996
Mol Cell. 2012 Jul 27;47(2):320-9
pubmed: 22841003
Chem Biol. 2015 Nov 19;22(11):1491-1504
pubmed: 26548611
Cell. 2007 Dec 28;131(7):1248-59
pubmed: 18160036
Mol Cell Biol. 2017 Sep 26;37(20):
pubmed: 28760773
Cell. 2012 Nov 9;151(4):807-820
pubmed: 23122649
Cell. 2014 Sep 25;159(1):108-121
pubmed: 25259924
Nature. 2009 Dec 17;462(7275):935-9
pubmed: 20016603
Mol Cell. 2015 Jan 8;57(1):123-37
pubmed: 25533188
Nature. 2019 Jan;565(7741):659-663
pubmed: 30675059
Nat Struct Mol Biol. 2017 Dec;24(12):1124-1131
pubmed: 29106411

Auteurs

Jonathan Barroso-González (J)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Laura García-Expósito (L)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Song My Hoang (SM)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Michelle L Lynskey (ML)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Justin L Roncaioli (JL)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Arundhati Ghosh (A)

Department of Microbiology and Molecular Genetics, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Callen T Wallace (CT)

Department of Cell Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Marco de Vitis (M)

Department of Science, University of Rome "ROMA TRE", 00146 Rome, Italy.

Mauro Modesti (M)

Cancer Research Center of Marseille, CNRS UMR7258, Inserm UMR1068, Aix Marseille Université U105; Institut Paoli Calmettes, 27 Boulevard Lei Roure CS30059, 13273 Marseille, Cedex 09, France.

Kara A Bernstein (KA)

Department of Microbiology and Molecular Genetics, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Saumendra N Sarkar (SN)

Department of Microbiology and Molecular Genetics, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Simon C Watkins (SC)

Department of Cell Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Roderick J O'Sullivan (RJ)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA. Electronic address: osullivanr@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH